Type B PD Solution Reaction — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Type B reaction to PD solution (non-IgE-mediated complement activation) – associated with certain PD solution formulations; management is stopping the solution, treating symptoms, and switching to an alternative PD solution
Type B (slow-onset) reactions to PD solutions are complement-mediated and present 2-12 hours after exposure. Symptoms include chest/back pain, fever, and sometimes respiratory distress. They are associated with specific solution components or contaminants. Management: stop the offending solution, supportive care, and switch to a different PD solution brand/formulation. Type B reactions are distinct from Type A (acute, within minutes – anaphylactoid) and from PD peritonitis (which has cloudy effluent, elevated WCC, and positive cultures). Documenting the exact solution batch is important for pharmacovigilance.
Reference: ISPD – PD Solution Reactions; ERA-EDTA 2019